ResearcherNational Taiwan UniversityNo recent work listed
Tiffany Ting‐Fang Shih
Matched on ORCID iD 0000-0002-3292-9688; OpenAlex author ID A5024002796. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 3
- Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PET Metabolic Activity, Clinical Stages, a… First author DOI 10.3390/diagnostics11091541↗
- Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.clnu.2018.02.016↗
- Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. Last author DOI 10.1007/s00259-018-3960-0↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yu‐Ting Chang · 3 shared papers, 2018–2021 · strength 0.32
- Paper Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PE… DOI 10.3390/diagnostics11091541↗
- Paper Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic c… DOI 10.1016/j.clnu.2018.02.016↗
- Paper Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. DOI 10.1007/s00259-018-3960-0↗
- Ming‐Chu Chang · 3 shared papers, 2018–2021 · strength 0.32
- Paper Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PE… DOI 10.3390/diagnostics11091541↗
- Paper Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic c… DOI 10.1016/j.clnu.2018.02.016↗
- Paper Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. DOI 10.1007/s00259-018-3960-0↗
- Bang‐Bin Chen · 2 shared papers, 2018–2021 · strength 0.22
- Paper Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PE… DOI 10.3390/diagnostics11091541↗
- Paper Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. DOI 10.1007/s00259-018-3960-0↗
- Yu‐Wen Tien · 2 shared papers, 2018–2021 · strength 0.22
- Paper Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PE… DOI 10.3390/diagnostics11091541↗
- Paper Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. DOI 10.1007/s00259-018-3960-0↗
- Mei‐Fang Cheng · 2 shared papers, 2018–2021 · strength 0.22
- Paper Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PE… DOI 10.3390/diagnostics11091541↗
- Paper Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. DOI 10.1007/s00259-018-3960-0↗
- Shih‐Hung Yang · 2 shared papers, 2018–2021 · strength 0.22
- Paper Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PE… DOI 10.3390/diagnostics11091541↗
- Paper Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. DOI 10.1007/s00259-018-3960-0↗
- Chih‐Horng Wu · 2 shared papers, 2018–2019 · strength 0.18
- Paper Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic c… DOI 10.1016/j.clnu.2018.02.016↗
- Paper Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. DOI 10.1007/s00259-018-3960-0↗
- Chih-Kai Chang · 1 shared paper, 2021 · strength 0.14
- Po‐Chin Liang · 1 shared paper, 2019 · strength 0.11
- Vladimir Konstantinovich Lyadov · 1 shared paper, 2019 · strength 0.11
- Ting‐Chun Kuo · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.